We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




MRI May Predict Adverse Tissue Reaction for Metal-On-Metal Hip Replacement Patients

By HospiMedica International staff writers
Posted on 08 Apr 2013
Magnetic resonance imaging (MRI) can detect a failing, or potentially failing, metal-on-metal hip implant (MoM) in the early stages, according to new research.

The study’s findings were presented at the 2013 annual meeting of the American Academy of Orthopedic Surgeons (AAOS), held in Chicago (IL, USA), March 19-23. More...
Early detection can result in timely revision surgery, slashing the risk for additional tissue damage and pain.

Alissa J. Burge, MD, from the Hospital for Special Surgery (HSS; New York, NY, USA), and researchers reviewed the MRI scans of 70 patients who ultimately underwent revision surgery for a failed MoM implant. The images were assessed for the presence of swelling, tissue damage, and other characteristics. The researchers discovered that MRI is very sensitive and specific to identifying tissue damage in MoM total hip replacement (THR) patients. Early identification of at-risk patients can result in well-timed revision surgery, when necessary, decreasing pain and future damage to surrounding hip tissue.

In December 2012, the Academy issued an information statement on metal-on-metal hip arthroplasty, recommending a “low threshold” for beginning the evaluation of a patient with a MoM hip replacement, as “early recognition and diagnosis will facilitate the initiation of appropriate treatment prior to significant adverse biological reactions.”

The report also provided a detailed summary of a variety of diagnostic and treatment tools to lessen patient discomfort, and defined when to rapidly begin treatment, and if needed, revision.

Related Links:

Hospital for Special Surgery



Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Surgical Dressing
ALLEVYN Ag+ SURGICAL
Medical Adhesive
MED 5570U
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.